Ledyard, CT, United States of America

Eugene F Fiese

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1988-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugene F Fiese. Retrieved from https://idiyas.com/inventor/eugene-f-fiese

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1988-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Eugene F. Fiese

Introduction

Eugene F. Fiese is a notable inventor based in Ledyard, CT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work has been instrumental in advancing medical science and improving patient care.

Latest Patents

Among his latest patents is the compound (1S,2S)-1-(4-hydroxyphenyl)-2-(4-), which showcases his innovative approach to drug development. Another significant patent is the transformation product of thiosporamicin, which highlights his expertise in pharmaceutical chemistry.

Career Highlights

Eugene F. Fiese is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.

Collaborations

Throughout his career, Eugene has worked alongside talented colleagues such as Marta M. Andino and Terry G. Sinay. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical products.

Conclusion

Eugene F. Fiese's contributions to the field of pharmaceuticals through his patents and collaborations exemplify the impact of dedicated inventors in advancing medical science. His work continues to inspire future innovations in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…